Chronic Heart Failure Clinical Trial
Official title:
Early Homebased Rehabilitation for Patients With Severe Heart Failure - An Intersectoral Randomized Controlled Trial
The purpose of this study is to investigate the effect of an early, coordinated rehabilitation intervention for patients with severe heart failure in NYHA class III and IV with a ejection fraction of <40% of normal cardiac function measured on frequency of readmissions, physical ability and participation in activities of daily living and quality of life.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | July 2016 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients admitted to the Gentofte Hospital due to heart failure. - Patients with a functional equivalent to NYHA grade III or IV - Patients with ejection fraction <40% - Patients who score between10-15 in the total score for question 3 dealing with physical functioning in SF-36 questionnaire on health status - Patients who lives in Gentofte Municipality or Lyngby Tårbæk Municipality. - Patients who can speak and understand Danish Exclusion Criteria: - Patients with cognitive and psychological problems that prevents cooperation (aphasia, dementia, severe depression). - Patients with terminal illness with expected death within a year. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Occupational Therapy and Physiotherapy, Copenhagen University Hospital Gentofte, | Copenhagen | Gentofte |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Gentofte, Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Readmission due to heart failure | assessed one year after inclusion | No | |
Secondary | Physical capacity | measured by the Morton Mobility Index, Timed Up & Go and Modified Sit to Stand Test | Assessed at baseline, after 6 weeks, after 6 month and after one year | No |
Secondary | Activity of Daily Living | Recorded at an ADL interview to assess the performance of everyday activities | Assessed at baseline, after 6 weeks, after 6 month and after one year | No |
Secondary | Number of total hospital admissions | at baseline, after 6 weeks, after 6 month and after one year | No | |
Secondary | Exercise Compliance | registration of exercise | at baseline, after 6 weeks, after 6 month and after one year | No |
Secondary | Anxiety and depression | measured by Hospital Anxiety and Depression Scale (HAD) | at baseline, after 6 weeks, after 6 month and after one year | No |
Secondary | Quality of life | measured by The Minnesota Living with Heart Failure Questionnaire | at baseline, after 6 weeks, after 6 month and after one year | No |
Secondary | Number of patients who starts outpatient cardiac rehabilitation after intervention (municipality or hospital) | at 6 weeks, after 6 month and after one year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03597646 -
The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure
|
N/A | |
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|
||
Not yet recruiting |
NCT06002321 -
Right Ventricular Dysfunction in Chronic Heart Failure
|